# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Sigmund Freud (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET005-SYN
- Date: 2026-06-01
- Fictional facility: St. Posthumous Health Center
- Fictional author: Anton Reinholt, MD
- Calendar frame: modern shifted

## What we are working on

- He doubts he can work without cigars and has failed to stop many times **S**
- His obturator leaks and rubs, which makes speaking, eating and working harder **S**
- He fears the cancer coming back **S**

## Your goals

- Stop smoking cigars completely, at a pace he chooses, using varenicline and nicotine replacement. Target: 2026-10-26. Recorded outcome: Twenty cigars a day to six by six weeks; no smoking since the quit date apart from one cigar in the second week; about fourteen weeks without smoking at five months. **S**
- An obturator that seals and does not rub, so that speech is clear and liquids do not leak into his nose. Target: 2026-08-24. Recorded outcome: Reline at two weeks; new definitive obturator fitted at twelve weeks; speech clear and no nasal leakage. **S**
- Pain at 3 of 10 or less without opioids. Target: 2026-10-26. Recorded outcome: Pain 6 to 2 of 10 on scheduled acetaminophen with a well-fitting obturator. **S**
- Regain weight to at least 60 kg with a normal albumin. Target: 2026-10-26. Recorded outcome: Weight 58.4 to 60.6 kg; albumin 3.4 to 3.9 g/dL. **S**

## What we agreed to do

- Tobacco: a nonjudgmental assessment of readiness and of what cigars do for him; varenicline started now, before a quit date, with a plan to cut down and then stop; combination nicotine replacement (patch and lozenge) added from the quit date; cigars are counted like any other tobacco; weekly behavioral support by phone with the national quitline and in clinic; relapse treated as part of the process. Guideline: Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline (2020); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021) **S**
- Maxillofacial prosthodontics consultation for a worn, poorly sealing obturator with pain, hypernasal speech and nasal leakage, and for dental care. Guideline: NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers, Version 2.2026 (follow-up and survivorship) (2026); American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016) **S**
- Head and neck cancer survivorship: yearly examination of the mouth, defect and neck by his head and neck surgeon (more than five years after treatment), self-examination of the mouth, prompt review of any sore, lump, bleeding or change that lasts two weeks, imaging only for symptoms, and counseling on the risk of second primary cancers of the mouth, throat, larynx, esophagus and lung, which stopping smoking lowers. Guideline: NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers, Version 2.2026 (follow-up and survivorship) (2026); American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016) **S**
- Chronic pain: scheduled acetaminophen up to 3,000 mg a day, a well-fitting obturator, warm saline rinses, and no long-term opioids; the plan is reviewed at each visit with a pain score. Guideline: American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016); CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022) **S**
- Nutrition: dietitian advice on soft high-protein meals, oral nutrition supplements twice daily, weight at each visit and albumin rechecked. Guideline: American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016) **S**
- Prosthodontic care: chairside reline and flange adjustment now, a new definitive obturator, nightly cleaning and an overnight soak, high-fluoride toothpaste, dental cleaning every three months, nicotine lozenge rather than gum, and speech and swallowing therapy sessions with a speech-language pathologist after the reline. Guideline: NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers, Version 2.2026 (follow-up and survivorship) (2026); American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016) **S**
- Cardiovascular risk: lipid panel and 10-year risk estimate; a statin discussed with him once the smoking plan is under way. Guideline: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication (2022) **S**

## Follow-up

- 2026-06-01: Establishing primary care seven years after maxillectomy for palatal cancer: about twenty cigars a day, a worn obturator, pain and weight loss **S**
- 2026-06-15: Two-week review with the maxillofacial prosthodontics consultation: obturator reline, speech, swallowing and dental care; varenicline at full dose **S**
- 2026-07-13: Six-week review: smoking down by two thirds, setting a quit date, pain and weight **S**
- 2026-08-24: Twelve-week review: five weeks without smoking, the new obturator and survivorship surveillance **S**
- 2026-09-28: Subsequent annual wellness visit **S**
- 2026-10-26: Five-month review: abstinence, lung and aortic screening results, pain, weight and the survivorship plan **S**

This teaching document does not replace care from a qualified clinician.
